Skip to Content
Merck
CN
  • Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.

Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.

JACC. Basic to translational science (2020-10-06)
Raphaëlle Bourgeois, Romain Devillers, Nicolas Perrot, Audrey-Anne Després, Marie-Chloé Boulanger, Patricia L Mitchell, Jakie Guertin, Patrick Couture, Michael B Boffa, Corey A Scipione, Philippe Pibarot, Marlys L Koschinsky, Patrick Mathieu, Benoit J Arsenault
ABSTRACT

Our objectives were to determine whether autotaxin (ATX) is transported by lipoprotein(a) [Lp(a)] in human plasma and if could be used as a biomarker of calcific aortic valve stenosis (CAVS). We first found that ATX activity was higher in Lp(a) compared to low-density lipoprotein fractions in isolated fractions of 10 healthy participants. We developed a specific assay to measure ATX-Lp(a) in 88 patients with CAVS and 144 controls without CAVS. In a multivariable model corrected for CAVS risk factors, ATX-Lp(a) was associated with CAVS (p = 0.003). We concluded that ATX is preferentially transported by Lp(a) and might represent a novel biomarker for CAVS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Goat Anti-Rabbit IgG Antibody, Peroxidase Conjugated, 1 mg/mL (after reconstitution), Chemicon®
Sigma-Aldrich
Anti-Apolipoprotein(a) Antibody, clone LPA4, clone LPA4, from mouse